ArticleEuropean journal of clinical pharmacology2024

Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?

Onur Turan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.